| Patent Number |
Title Of Patent |
Date Issued |
| 6663883 |
Matrix adhering to nasal mucosa |
December 16, 2003 |
| This invention provides a matrix adhering to the nasal mucosa which allows improved transfer into the brain of a drug exerting its effect in the brain and is capable of continuously supplying the drug into the brain. This matrix contains a polyglycerol fatty acid ester, the drug exerting |
| 6428813 |
Gastrointestinal mucosa-adherent pharmaceutical composition |
August 6, 2002 |
| In order to provide a composition having a long gastroduodenal residence time and exhibiting an improved efficacy, is provided a gastrointestinal mucosa-adherent composition comprising an active ingredient and a material which swells a viscogenic agent capable of being viscous with water |
| 6368635 |
Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition |
April 9, 2002 |
| A solid matrix composition which is solid at ambient temperature, which comprises a viscogenic agent, such as an acrylic acid polymer, capable of developing viscosity on contact with water, as dispersed at least in the neighborhood of the surface layer of a matrix particle containing a |
| 6319904 |
Formulation comprising antibacterial substance and antiulcer substance |
November 20, 2001 |
| The present invention includes a formulation which comprises an antibacterial substance and an antiulcer substance, wherein at least either of them is formulated into a gastrointestinal mucosa-adherent solid preparation. The formulation of the present invention shows long retention t |
| 5948773 |
Formulation comprising antibacterial substance and antiulcer substance |
September 7, 1999 |
| The present invention includes a formulation which comprises an antibacterial substance and an antiulcer substance, wherein at least either of them is formulated into a gastrointestinal mucosa-adherent solid preparation. The formulation of the present invention shows long retention t |
| 5846562 |
Oral composition of fumagillol derivative |
December 8, 1998 |
| The present invention relates to a pharmaceutical composition for oral administration in which a fumagillol derivative is stabilized and exhibits remarkable antiangiogenesis activity in oral administration. |
| 5731006 |
Gastrointestinal mucosa-adherent granules, pharmaceutical preparations and a coating composition |
March 24, 1998 |
| A solid matrix composition which is solid at ambient temperature, which comprises a viscogenic agent, such as an acrylic acid polymer, capable of developing viscosity on contact with water, as dispersed at least in the neighborhood of the surface layer of a matrix particle containing a |
| 5576025 |
Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition |
November 19, 1996 |
| A solid matrix composition which is solid at ambient temperature, which comprises a viscogenic agent, such as an acrylic acid polymer, capable of developing viscosity on contact with water, as dispersed at least in the neighborhood of the surface layer of a matrix particle containing a |
| 5162057 |
Coatings for stable sustained release preparations |
November 10, 1992 |
| Fatty acid esters of polyglycerols, such as stearic acid penta(tetra)glyceryl ester, behenic acid hexa(tetra)glyceryl ester, lauric acid mono(deca)glyceryl ester, oleic acid di(tri)glyceryl ester, linolic acid di(hepta)glyceryl ester, palmitic acid deca(deca)glyceryl ester, etc. are |
